BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 20216908)

  • 1. Interleukin 18 and cardiovascular disease in HIV-1 infection: a partner in crime?
    Torre D; Pugliese A
    AIDS Rev; 2010; 12(1):31-9. PubMed ID: 20216908
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [HIV infection, antiretroviral therapy, and endothelium].
    Hürlimann D; Weber R; Enseleit F; Lüscher TF
    Herz; 2005 Sep; 30(6):472-80. PubMed ID: 16170677
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The basis and management of metabolic abnormalities associated with cardiovascular risk in human immunodeficiency virus infection and its treatment.
    Crook M
    Ann Clin Biochem; 2007 May; 44(Pt 3):219-31. PubMed ID: 17456292
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiovascular complications and atherosclerotic manifestations in the HIV-infected population: type, incidence and associated risk factors.
    Boccara F
    AIDS; 2008 Sep; 22 Suppl 3():S19-26. PubMed ID: 18845918
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endothelial and platelet function alterations in HIV-infected patients.
    Gresele P; Falcinelli E; Sebastiano M; Baldelli F
    Thromb Res; 2012 Mar; 129(3):301-8. PubMed ID: 22192157
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [HIV-related cardiovascular risk factors].
    Masiá M; Gutiérrez F
    Enferm Infecc Microbiol Clin; 2009 Sep; 27 Suppl 1():17-23. PubMed ID: 20172411
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antigenic stimulation in the simian model of HIV infection yields dilated cardiomyopathy through effects of TNFalpha.
    Yearley JH; Mansfield KG; Carville AA; Sokos GG; Xia D; Pearson CB; Shannon RP
    AIDS; 2008 Mar; 22(5):585-94. PubMed ID: 18316999
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dyslipidaemia and cardiovascular risk in HIV infection.
    Kulasekaram R; Peters BS; Wierzbicki AS
    Curr Med Res Opin; 2005 Nov; 21(11):1717-25. PubMed ID: 16307691
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.
    Van Vaerenbergh K
    Verh K Acad Geneeskd Belg; 2001; 63(5):447-73. PubMed ID: 11813503
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endothelial function is impaired in HIV-infected patients with lipodystrophy.
    Masiá M; Padilla S; García N; Jarrin I; Bernal E; López N; Hernández I; Gutiérrez F
    Antivir Ther; 2010; 15(1):101-10. PubMed ID: 20167996
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiovascular disease in HIV infection.
    Sudano I; Spieker LE; Noll G; Corti R; Weber R; Lüscher TF
    Am Heart J; 2006 Jun; 151(6):1147-55. PubMed ID: 16781213
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of interleukin-18 in the development and pathogenesis of AIDS.
    Iannello A; Samarani S; Debbeche O; Tremblay C; Toma E; Boulassel MR; Routy JP; Ahmad A
    AIDS Rev; 2009; 11(3):115-25. PubMed ID: 19654853
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular biological assessment methods and understanding the course of the HIV infection.
    Katzenstein TL
    APMIS Suppl; 2003; (114):1-37. PubMed ID: 14626050
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiovascular disease and toxicities related to HIV infection and its therapies.
    Zareba KM; Miller TL; Lipshultz SE
    Expert Opin Drug Saf; 2005 Nov; 4(6):1017-25. PubMed ID: 16255661
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiovascular disease in HIV infection.
    Sánchez-Torres RJ; García-Palmieri MR
    P R Health Sci J; 2006 Sep; 25(3):249-54. PubMed ID: 17203795
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effect of chronic Chlamydia infection with non-specific inflammation on cardiovascular complications in acute myocardial infarct].
    Jaber AJ; Murín J; Hricák V; Tomasovic B; Kinová S; Kozlíková K; Ghanem W; Radman A
    Vnitr Lek; 2003 Feb; 49(2):109-14. PubMed ID: 12728577
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of lymphomonocyte activation by HIV-1 glycoprotein gp120. Possible role in AIDS pathogenesis.
    Capobianchi MR
    J Biol Regul Homeost Agents; 1996; 10(4):83-91. PubMed ID: 9604776
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Physiopathology of cardiovascular disease in HIV-infected patients].
    Alonso-Villaverde Lozano C
    Enferm Infecc Microbiol Clin; 2009 Sep; 27 Suppl 1():33-9. PubMed ID: 20172413
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Rheumatoid arthritis, inflammation, and atherosclerosis].
    Hürlimann D; Enseleit F; Ruschitzka F
    Herz; 2004 Dec; 29(8):760-8. PubMed ID: 15599672
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular and cellular interactions of HIV-1/HTLV coinfection and impact on AIDS progression.
    Casoli C; Pilotti E; Bertazzoni U
    AIDS Rev; 2007; 9(3):140-9. PubMed ID: 17982939
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.